ArticleiScience2023

Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy.

Sasha A S Kjeldsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.